New funding for CAMK2 syndrome research
The van Woerden lab has recently received funding from the Merel Foundation to test the effect of candidate variants in the Camk2 genes, found in patients with neurodevelopmental disorder.
With this money we will use the PRiSM screen to determine whether the variants are indeed harmful and in what way. This information is crucial for the genotype-phenotype correlation analysis, which is important to ultimately determine prognoses for newly found mutations. In addition, this helps with the direct diagnosis of the patient and the possible treatment options. The van Woerden is very pleased with this award.
The de Merel foundation aims to promote health care in the broadest sense of the word, including by coordinating and stimulating scientific research in the field of health care.